AMULYA PINGALI: Open Payments
NPI 1962190660 · ONEONTA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 23 payments from 7 companies in 2025. Trend: 2023 $324 · 2024 $845 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $91 |
| Novo Nordisk Inc | 4 | $85 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Exact Sciences Corporation | 3 | $56 |
| PFIZER INC. | 2 | $56 |
| ABBVIE INC. | 2 | $49 |
| Abbott Laboratories | 2 | $40 |
Products named: The Cologuard Plus Collection Kit, ELIQUIS, SHINGRIX, VRAYLAR, Ozempic, FREESTYLE LIBRE 3, AIRSUPRA, FARXIGA.
Industry payments across NY — which companies pay providers there.
